Drugs / MF59 - ATIV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02529904 | Aug 2015 → Apr 2016 | influenza | University of Oxford | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MF59 - ATIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02529904 ↗ |
| Modality | Vaccine | “MF59 Adjuvanted Trivalent Influenza Vaccine (ATIV)” NCT02529904 ↗ |